Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2008
07/03/2008US20080161284 excellent purity; bradycardic agent; myocardial ischaemia: angina pectoris, myocardial infarct, arrhythmia disturbances, heart failure; structure confirms by X-ray diffraction data; industrial scale, storage stability
07/03/2008US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
07/03/2008US20080161270 Angiogenesis inhibitors
07/03/2008US20080161258 Hsp and Supraventricular Arrhythmia
07/03/2008US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use
07/03/2008US20080161241 Preventing sustained monomorphic ventricular tachycardia following myocardial ischemia by administering etanercept; or bortezomib; inhibits substantial loss of beta-adrenergic receptor kinase (beta-ARK) activity
07/03/2008US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
07/03/2008US20080161237 Formulation For a Viptadil
07/03/2008US20080160576 Anti-alphabeta3 humanized monoclonal antibodies
07/03/2008US20080160553 Method of preparing heart muscle cells and method of searching for remedy for heart diseases
07/03/2008US20080160119 Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect
07/03/2008US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects
07/03/2008US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella
07/03/2008US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders
07/03/2008US20080160033 Novel Screening Method
07/03/2008US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas
07/03/2008US20080160023 Using type-1 peroxisomal targeting signal protein as tool in identifying modulators for prevention and treatment of heart ischemia, dietary obesity, fatty liver disease and hypercholesterolemia
07/03/2008US20080160013 Using immunoglobulin fusion comprising intergrin binding protein and src homology domains as therapeutic tool in treatment and prevention of cell proliferative and atherosclerotic disorders
07/03/2008US20080160005 Interleukin-6 suppressive agent
07/03/2008US20080159997 Transplants for myocardial scars
07/03/2008US20080159989 Method of Promoting the Differentiation of Staminal Cells
07/03/2008US20080159956 diagnosing and analyzing a mammal who has a risk of developing the disease, using antibody, or fragments thereof, which has a binding site specific for integrin
07/03/2008CA2709428A1 Adp-ribosyl transferase fusion variant proteins
07/03/2008CA2673922A1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
07/03/2008CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors
07/03/2008CA2673920A1 Cycloalkylamine substituted isoquinoline derivatives
07/03/2008CA2673919A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
07/03/2008CA2673918A1 Substituted isoquinoline and isoquinolinone derivatives
07/03/2008CA2673916A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
07/03/2008CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008CA2673391A1 Pharmaceutical composition using aliskiren and avosentan
07/03/2008CA2673307A1 Spiro-piperidine derivatives
07/03/2008CA2672428A1 Abca1 elevating compounds
07/03/2008CA2670651A1 Reduction of cardiovascular symptoms
07/02/2008EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene
07/02/2008EP1939286A1 Novel peptides
07/02/2008EP1939205A1 Tricyclic compound
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939194A1 Bicyclic aromatic substituted pyridone derivative
07/02/2008EP1939189A1 Derivative having ppar agonistic activity
07/02/2008EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents
07/02/2008EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
07/02/2008EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase
07/02/2008EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression
07/02/2008EP1938819A2 Use of specific cyclolignans
07/02/2008EP1938818A2 Use of specific cyclolignans
07/02/2008EP1938812A1 Pharmaceutical composition using aliskiren and avosentan
07/02/2008EP1938810A1 Ameliorating agent for metabolic syndrome
07/02/2008EP1937714A2 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
07/02/2008EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof
07/02/2008EP1937681A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
07/02/2008EP1937641A2 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
07/02/2008EP1937640A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
07/02/2008EP1937279A2 Use of inhibitors of pi3k-c2a for the treatment of apoptosis-related disorders
07/02/2008EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof
07/02/2008EP1937254A2 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology
07/02/2008EP1937245A1 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
07/02/2008EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
07/02/2008EP1501808B1 Tachykinin receptor antagonists
07/02/2008EP1496838A4 Substituted amides
07/02/2008EP1474425B9 Deazapurines and uses thereof
07/02/2008EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors
07/02/2008EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase
07/02/2008EP1141003B9 Methods of activation of SGK by phosphorylation.
07/02/2008EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
07/02/2008CN101213281A 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament
07/02/2008CN101213213A Cardiovascular disease therapies
07/02/2008CN101213184A Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
07/02/2008CN101213174A Oxindole compounds and their uses as therapeutic agents
07/02/2008CN101210011A Quinolines compounds and their intermediates, preparation method and application
07/02/2008CN101209976A Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor
07/02/2008CN101209348A Elastic nano vesicle carrier and preparation and application thereof
07/02/2008CN101209328A Lipophilic effective extract of Chinese green onion and extracting method
07/02/2008CN101209312A Digitalis extract and preparation thereof
07/02/2008CN101209303A Chinese medicinal oral liquid with heat-clearing and detoxication, antimicrobial and anti-inflammation efficacy
07/02/2008CN101209302A Heat-clearing and detoxication traditional Chinese medicine preparation and preparation thereof
07/02/2008CN101209288A Corydalis decumbentis orally disintegrating tablets
07/02/2008CN101209281A Application of high content salvianolate in preparing medicament for treating cerebral ischemia and oxygen deficiency
07/02/2008CN101209265A Medicine for treating inner hemorrhoids
07/02/2008CN101209256A Polydatin medicinal composition containing polyvinyl pyrrolidone
07/02/2008CN101209245A Particle containing amlodipine and orally disintegrating tablets containing the same
07/02/2008CN101209124A Fruit ganoderma lucidum health care beverage and preparation thereof
07/02/2008CN100398661C Casein hydrolyzate, process for producing the same and use thereof
07/02/2008CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application
07/02/2008CN100398541C Pyrimidinone derivatives and 3-keto ester
07/02/2008CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5
07/02/2008CN100398526C 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
07/02/2008CN100398519C Tetracyclic benzamide derivatives and methods of use thereof
07/02/2008CN100398153C Combined pharmaceutical application of antiangiogenic drugs and photosensitizers
07/02/2008CN100398139C Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof
07/02/2008CN100398117C Medicine for treating coronary heart disease
07/02/2008CN100398113C Nano selenium of Melatonin and its preparation method
07/02/2008CN100398104C Medicament comprising combination of antithrombotic agent with pyrazolone derivative
07/02/2008CN100398003C Sanitary battercake of ginseng
07/01/2008US7393953 Polymeric acyl derivatives of indoles
07/01/2008US7393932 Endothelial cell expression patterns
07/01/2008US7393872 Sodium channel blocker compositions and the use thereof
07/01/2008US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis
07/01/2008US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis
07/01/2008US7393841 for improved microcirculation, cryo-conservation of blood components such as erythrocytes of granulocytes, and as sedimentation aid in cell separation in connection with leucapheresis